home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

34.41 +1.37 (+4.15%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Collegium Pharmaceutical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 07, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 07, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 06, 2023

Via Benzinga

Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering

February 06, 2023

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Analyst Sees This 'Specialty Pharma' Stock Stuck Until Prescription Trends Improve ↗

August 08, 2022

Via Benzinga

Recap: Collegium Pharmaceutical Q1 Earnings ↗

May 10, 2022

Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results

February 06, 2023

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium Provides 2023 Financial Guidance

January 04, 2023

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Appeals Court Affirms Validity of Collegium’s Belbuca® Patents

December 22, 2022

Ruling bars ANDA filer Alvogen from entering market until 2032 patent expiry

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference

November 22, 2022

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Why Collegium Pharmaceutical's Shares Are Trading Higher Today ↗

April 05, 2022

Via Benzinga

Collegium Reports Third Quarter 2022 Financial Results

November 03, 2022

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Report Third Quarter 2022 Financial Results on November 3, 2022

October 20, 2022

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022 ↗

August 08, 2022

Via Benzinga

7 Micro-Cap Stocks to Take a Chance on Now ↗

June 04, 2022

Despite (or because of) their size, some micro-cap stocks, have good value and are overlooked and should be considered by investors.

Via InvestorPlace

A Preview Of Collegium Pharmaceutical's Earnings ↗

May 09, 2022

Collegium Pharmaceutical (NASDAQ:COLL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

May 09, 2022

What Defines a Value Stock?

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

May 02, 2022

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

Analyst Ratings For Collegium Pharmaceutical ↗

April 06, 2022

Over the past 3 months, 4 analysts have published their opinion on Collegium Pharmaceutical (NASDAQ:COLL) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

February 15, 2022

JP Morgan raised Ralph Lauren Corporation (NYSE: RL) price target from $137 to $142. Ralph Lauren shares rose 1.2% to $124.00 in pre-market trading.

Via Benzinga

BDSI Stock Alert: The Deal Sending Little-Known BioDelivery Skyrocketing Today ↗

February 14, 2022

Today, a big takeover announcement has sent shares of BioDelivery and BDSI stock soaring more than 50% on investor enthusiasm for this deal.

Via InvestorPlace

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

32 Stocks Moving In Monday's Mid-Day Session ↗

February 14, 2022

Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares jumped 51.9% to $5.53. Collegium Pharmaceutical will acquire BioDelivery Sciences International at $5.60...

Via Benzinga

52 Biggest Movers From Yesterday ↗

February 15, 2022

Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences...

Via Benzinga

Collegium Pharma Broadens Its Pain Portfolio With $600M BioDelivery Sciences Deal ↗

February 14, 2022

Collegium Pharmaceutical Inc (NASDAQ: COLL) will acquire BioDelivery Sciences International Inc (NASDAQ: BDSI) at $5.60 per share in an all-cash transaction,...

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

February 07, 2022

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

January 03, 2022

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

Collegium Pharmaceutical, inc (COLL) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

COLL earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com